The rise of Candida auris: from unique traits to co-infection potential
Candida auris is a multidrug resistant (MDR) fungal pathogen with a crude mortality rate of 30-60%. First identified in 2009, C. auris has been rapidly rising to become a global risk in clinical settings and was declared an urgent health threat by the Centers for Disease Control and Prevention (CDC)...
Saved in:
| Main Authors: | Nadine B. Egger, Katharina Kainz, Adina Schulze, Maria A. Bauer, Frank Madeo, Didac Carmona-Gutierrez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shared Science Publishers OG
2022-08-01
|
| Series: | Microbial Cell |
| Subjects: | |
| Online Access: | http://microbialcell.com/researcharticles/2022a-egger-microbial-cell/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<i>Candida auris</i> — a New Pathogen of Nosocomial Infections
by: T. V. Chernenkaya
Published: (2024-09-01) -
Clinical and laboratory features of patients with Candida auris cultures, compared to other Candida, at a South African Hospital
by: Amirah Parak, et al.
Published: (2022-01-01) -
Patterns and Predictors of <i>Candida auris</i> Candidemia with Multidrug-Resistant Bacterial Co-Infections: Results from the CANDI-MDR Study
by: Karolina Akinosoglou, et al.
Published: (2025-05-01) -
Progression from Candida auris Colonization Screening to Clinical Case Status, United States, 2016–2023
by: Anna D. Baker, et al.
Published: (2025-08-01) -
Clinical case of effective treatment of invasive mycosis caused by polyresistant strain of Candida auris
by: L. V. Selivanova, et al.
Published: (2024-08-01)